I had a review and by-monthly injection on my left eye yesterday that is my good eye! I received good news to say that it it was dry and Eyelea was working well for me, 10 days ago I had new of the deterioration of the wet right eye, so that must be seen each month promptly.
I thought I would ask the consultant about the new drug for us Brolucizumab a new anti-VEGF drug that, in phase III clinical trials, that can last as long as 12 weeks between treatments. FDA approval is expected in 2019.
She was a little more communicative this visit and said yes, she was looking forward to having more effective anti-VEGF drugs that will give us a longer periods between injections, she mentioned even every 6 months which would be great!
I asked her if she thought it will be available on the NHS, she was hopeful but said it must get through each trust.
I further read that that Novartis the makers of Brolucizumab are going to work on it be be given by eye drops and ocular implant. Let’s hope this will be soon.
Let’s all keep as positive as is possible.
Love to all
Ann